FASLG and neoplasm: Activation of these immune effectors causes upregulation of FasL on the plasma membrane, increasing their cytolytic potential and when FasL on an effector cell ligates with CD95 on the surface of a target cell, such as a tumour cell, it instigates formation of a death-induced signalling complex and initiation of the caspase proteolytic cascade.